Literature DB >> 9826735

Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1.

L H Lim1, E Solito, F Russo-Marie, R J Flower, M Perretti.   

Abstract

In this study we investigated, using intravital microscopy, how neutrophil extravasation across mouse mesenteric postcapillary venules is inhibited by the glucocorticoid-regulated protein lipocortin (LC; also termed annexin) 1. Intraperitoneal injection of 1 mg of zymosan into mice induced neutrophil rolling on the activated mesenteric endothelium followed by adhesion (maximal at 2 hr: 5-6 cells per 100-micrometers of vessel length) and emigration (maximal at 4 hr: 8-10 cells per high-powered field). Treatment of mice with human recombinant LC1 (2 mg/kg s.c.) or its mimetic peptide Ac2-26 (13 mg/kg s.c.) did not modify cell rolling but markedly reduced (>/=50%) the degree of neutrophil adhesion and emigration (P < 0.05). Intravenous treatment with peptide Ac2-26 (13 mg/kg) or recombinant human LC1 (0.7-2 mg/kg) promoted detachment of neutrophils adherent to the endothelium 2 hr after zymosan administration, with adherent cells detaching within 4.12 +/- 0.75 min and 2.36 +/- 0.31 min, respectively (n = 20-25 cells). Recruitment of newly adherent cells to the endothelium was unaffected. The structurally related protein LC5 was inactive in this assay, whereas a chimeric molecule constructed from the N terminus of LC1 (49 aa) attached to the core region of LC5 produced cell detachment with kinetics similar to LC1. Removal of adherent neutrophils from activated postcapillary endothelium is a novel pharmacological action, and it is at this site where LC1 and its mimetics operate to down-regulate this aspect of the host inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826735      PMCID: PMC24408          DOI: 10.1073/pnas.95.24.14535

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo.

Authors:  U H Von Andrian; P Hansell; J D Chambers; E M Berger; I Torres Filho; E C Butcher; K E Arfors
Journal:  Am J Physiol       Date:  1992-10

2.  Structural requirements for annexin I-S100C complex-formation.

Authors:  J Seemann; K Weber; V Gerke
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

Review 3.  Signaling mechanisms and the activation of leukocyte integrins.

Authors:  R A Newton; M Thiel; N Hogg
Journal:  J Leukoc Biol       Date:  1997-04       Impact factor: 4.962

4.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

5.  Comparison of leukotriene B4-induced neutrophil migration through different cellular barriers.

Authors:  T B Casale; M K Abbas
Journal:  Am J Physiol       Date:  1990-04

6.  Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition.

Authors:  J P Mira; T Dubois; J P Oudinet; S Lukowski; F Russo-Marie; B Geny
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

7.  Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.

Authors:  K A Haines; S L Kolasinski; B N Cronstein; J Reibman; L I Gold; G Weissmann
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

8.  Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules.

Authors:  K Bienvenu; D N Granger
Journal:  Am J Physiol       Date:  1993-05

9.  Detection of intracellular lipocortin 1 in human leukocyte subsets.

Authors:  E F Morand; P Hutchinson; A Hargreaves; N J Goulding; N W Boyce; S R Holdsworth
Journal:  Clin Immunol Immunopathol       Date:  1995-08

10.  Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5.

Authors:  C Becherucci; M Perretti; E Solito; C L Galeotti; L Parente
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more
  65 in total

1.  Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation.

Authors:  E Solito; C de Coupade; S Canaider; N J Goulding; M Perretti
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.

Authors:  Amrita Ahluwalia; Paul Foster; Ramona S Scotland; Peter G McLean; Anthony Mathur; Mauro Perretti; Salvador Moncada; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-23       Impact factor: 11.205

3.  Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages.

Authors:  Simon Yona; Julia C Buckingham; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

Review 4.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

5.  Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: implications for annexin-induced membrane aggregation.

Authors:  Nien-Jen Hu; Jeremy Bradshaw; Hans Lauter; Julia Buckingham; Egle Solito; Andreas Hofmann
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

Review 6.  Endogenous lipid mediators in the resolution of airway inflammation.

Authors:  O Haworth; B D Levy
Journal:  Eur Respir J       Date:  2007-11       Impact factor: 16.671

Review 7.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

8.  Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.

Authors:  Vincenzo Brancaleone; Jesmond Dalli; Stefania Bena; Roderick J Flower; Giuseppe Cirino; Mauro Perretti
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

9.  The formylpeptide receptor 2 (Fpr2) and its endogenous ligand cathelin-related antimicrobial peptide (CRAMP) promote dendritic cell maturation.

Authors:  Keqiang Chen; Yi Xiang; Jiaqiang Huang; Wanghua Gong; Teizo Yoshimura; Qun Jiang; Lino Tessarollo; Yingying Le; Ji Ming Wang
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

10.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.